[Balance-sheet after 5-years of beta-blocker use in psychiatry. General considerations on beta-active substances].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001007:Anxiety / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D009497:Neurotic Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy; D013315:Stress, Psychological / Q000187:drug effects
D000319:Adrenergic beta-Antagonists
Bilan de cinq années d'utilisation des substances bêta-bloquantes en psychiatrie. Réflexions générales sur les substances bêta-actives.